hnRNP A2B1 as a promising therapeutic target for radiomodulatory drug development: evidence from computational and experimental studies
hnRNP A2B1作为放射调节药物开发的潜在治疗靶点:来自计算和实验研究的证据
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1704625
Lubinets, N S; Tonkii, I S; Sazonova, V A; Dutta, K; Putintseva, A E; Volkova, O O; Skorb, E V; Zun, P; Ruzov, A; Kravtsov, V Yu; Shityakov, S